DOI:
10.1039/C4RA07710E
(Communication)
RSC Adv., 2014,
4, 48433-48437
A self-assembled π-conjugated system as an anti-proliferative agent in prostate cancer cells and a probe for intra-cellular imaging†
Received
28th July 2014
, Accepted 24th September 2014
First published on 24th September 2014
Abstract
Multifunctional π-conjugated systems derived from renewable resource that self-assemble into supramolecular structures are reported. The aggregation of compounds in different solvents strongly influences their optical properties. These π-conjugated molecules can be used for live cell imaging applications. They also show low cytotoxicity in fibroblasts and suppress proliferation in PC3 prostate cancer cells.
The self-assembly of low molecular weight building blocks to form diverse supramolecular architectures has attracted substantial interest due to their versatile applications in the fields of drug delivery, gene therapy, tissue engineering, enzyme immobilization, biosensors and construction of novel nano- or microscopic materials and devices.1–3 In this context molecular gels are known as a distinct class of soft materials. The gels are formed by the hierarchical assembly of low molecular weight organic gelators in a suitable solvent to structures such as fibrils, tapes, rods and tubes.4 The specific non-covalent interactions such as hydrogen bonding, π–π interaction, electrostatic and van der Waals interactions, hydrophilic–lipophilic balance (HLB) and other supramolecular weak forces are the driving forces for the self-assembly.5 Fluorescent supramolecular gels derived from biologically relevant molecules have received much attention because of their wide range of applications. Coumarin, a class of naturally occurring benzopyrone derivative has been used as an important pharmacophore, as it displays biological activities such as anticancer, antibacterial, antifungal, anticoagulant and anti-HIV, to name a few.6 The high fluorescence quantum yield and sensitivity toward the small changes in microenvironment are unique to the self-assembled pyrene derivatives, which enables them in applications in biomedical and biological research.7 These prospects drive us through extensive synthetic efforts to obtain more diverse pyrene-coupled coumarin based π-gelator with various hydrophobic tails, which could be used as drug carrier under high concentration, cell imaging agent under lower concentration and may exhibit therapeutic value too. Organogels derived from “π-gelators” are called “π-gels” which are self-assembled soft materials obtained from gelators with more than one aromatic π-unit.7 In the present studies, π-gelators were developed from renewable plant-derived resource, cashew nut shell liquid. Renewable resources have been used for several decades, there has been considerable focus on establishing and optimizing efficient materials, biologically relevant molecules, and large-scale production of chemicals and fuels that address the needs of the 21st century.8 Among the large number of renewable resources, cashew nutshell liquid (CNSL) is an important by-product obtained from the cashew nut industry.9 The major component of CNSL being cardanol, a bio based non-isoprene lipid, comprising of rich mixture of phenolic lipids: 5% of 3-n-pentadecylphenol (3-PDP), 50% of 3-(8Z-pentadecenyl)phenol, 16% of 3-(8Z,11Z-pentadecadienyl)phenol and 29% of 3-(8Z,11Z,14-pentadecatrienyl)phenol. The naturally occurring varying degree of cis-double bonds and an odd number of carbon chain with easily accessible saturated and unsaturated hydrocarbon chains are the unique features of cardanol.9,10 By harnessing electrophilic aromatic substitution reaction on phenol, we have synthesized both cardanol-aldehyde 2b and PDP-aldehyde 2c. The Knoevenagel reaction of compounds 2a–c with ethyl acetoacetate under optimized reaction condition led to the desired 3-acetylcoumarins 3a–c in good yields.11 π-gelators has been synthesized in good yields by aldol condensation of 3a–c with 1-pyrenecarboxaldehyde 4 (Scheme 1).
 |
| Scheme 1 Synthesis of multifunctional coumarin-coupled pyrene derivatives 5a–c. | |
Most of the pyrene based low molecular weight organogelator (LMOG) were prone to gelate solvents by using weak bonding mechanism in the presence of suitable solvents, even in the absence of hydrogen bonding.12 The supramolecular interaction of 5a by means of π–π stacking is inferred by NMR spectral analysis (Fig. S1†). Self-assembly of such an efficient gelator through non-covalent interactions into fibrillar aggregate that could immobilize the solvent molecule by capillary force to form a gel.4 Gelation studies using aromatic solvents, alcohols and vegetable oils were carried out (Table S1†). π-Gelators 5a and 5b exhibit excellent organogelation ability, showing critical gelation concentrations (CGCs) of 0.28 and 1.0% (w/v) respectively in higher alcohols such as decanol and dodecanol. π-conjugated molecule 5c did not form gel because of its enhanced hydrophobicity. Gel–sol transition temperature (Tg) was determined by typical test tube inversion method.4 In fact organogel formed by these compounds experience a gel to sol transition upon heating-cooling cycles (Tg = 65 °C). Morphology of the aggregates constitutive of the organogel in dodecanol has been identified using optical microscopy imaging deposited on glass slide. It shows thin fiber and twisted fiber-like structures of 100–200 nm thickness that bundle to form 3D network (Fig. 1). Morphology and properties of the π-gel resembles the self-assembly mechanism of π-conjugated molecule.7 Detailed gelation test indicated that compound 5a–5c do not form gel in any of the aromatic solvents tested and form stable gel in long chain alcohols and vegetable oils. Increasing the lipophilicity of the coumarin coupled pyrene derivative by introducing unsaturated and saturated alkyl chain decreases the gelation ability. At lower concentration, 5a–c in DMSO–water mixture (1 × 10−3 M solution) form self-assembled nano-sheets and nano-flakes (Fig. 1). Nanoparticle formation was further confirmed using particle size analyser (Zetasizer). The average sizes of self-assembled aggregates of 5a–c in DMSO–water mixture (1 × 10−3 M solution) are 194, 21 and 274 nm respectively (See ESI†).
 |
| Fig. 1 (a & b) Optical microscopy image of gel, 5a in dodecanol (0.28% w/v) under white light and fluorescence light respectively, inset show the formation of twisted fibers; (c) pictures of gel under UV light [left-5a in decanol, middle-5b in hazelnut oil and right-5a in dodecanol]; (d & e) HRTEM images of the self-assembly of 5a and 5b in DMSO–water mixture respectively; (f) picture of self-assembled solution of 5a in DMSO–water (1 : 1 ratio; 1 × 10−3 M solution) and (g) schematic representation of gel formation. | |
Small-angle X-ray diffraction (SAXD) was employed to acquire an additional insight into the structures that constitute the gel formed from supergelator 5a. XRD of the wet gel provides a Bragg's reflection at 1.35 nm, 1.30 nm, 1.26 nm which enunciates coumarin coupled pyrene, intercalated free decanol and hydrogen bonded decanol with the carbonyl group of coumarin-coupled pyrene derivative (Fig. S2†). This reflection is approximately equal to the molecular length of 5a, which was confirmed by molecular modelling studies using energy minimized calculations. Sharp peaks observed between 0.98–0.62 nm may arise from packing of dodecanol (both free and hydrogen bonded dodecanol) due to van der Waals interaction in gel network. The broad peak at 25° is assignable to the (001) aspect of π–π stacking of pyrene units.13
The UV-vis spectrum of compound 5a in acetonitrile shows three bands centred at 307, 392 and 427 nm, which are attributed to coumarin and pyrene unit under un-aggregated form. By changing the solvent to DMSO, the peak observed at 307 nm shifted to 352 nm and other peaks remained as same. This result implies the weak interaction of DMSO with coumarin core of 5a. Compound 5a in dodecanol show bands at 324 and 448 nm, red shift in all these peaks are due to molecular aggregation involving the formation of hydrogen bonding between carbonyl carbons of coumarin moiety and dodecanol, and π–π stacking of pyrene (Fig. 2a). Based on the results, we propose molecular arrangement of 5a in higher alcohol (Fig. 1).14 The UV titration of compound 5a dissolved in DMSO (1 × 10−5 M) with PBS buffer solution were then conducted. As expected, with the continuous addition of 100 μL of PBS buffer, absorbance band at 427 nm decreases with gradual increase in volume of PBS buffer solution. This property is attributed to the formation of nano-structures by self-assembly of pyrene and coumarin moieties (Fig. 2b). After the investigation of the self-assembly features of 5a in solution using UV-vis spectroscopy, we have evaluated the fluorescence property of 5a in solution and self-assembled state. The intense fluorescence observed in the gel state stimulated us to explore the emission property of compound 5a–c under different experimental conditions to confirm the influence of aggregation of the material. In self-assembled state, emission spectrum of 5a in dodecanol shows three peaks at 389, 409 and 554, which on further titration using dodecanol, the intensity of peak observed at 409 nm got decreased and 554 nm show blue shift and is attributed to the disassembly behaviour of self-assembled pyrene moiety (Fig. 2c). Similarly, compound 5a in DMSO shows three intense peaks at 397, 409 and 478 nm (Fig. S3†). The molecular aggregation in supergelator 5a dissolved in DMSO was induced by stepwise addition of 100 μL of PBS buffer and its emission behaviour was also followed. In the aggregated state, the emission spectrum covers a broad range of visible spectral range and exhibit vibronic coupling maximum at 414 and 576 nm. The drastic increase in emission intensity with a red shift in the aggregated state implies the formation of self-assembled structure (Fig. 2).15 We determined fluorescence quantum yields of 5a–c in different solvents (1 × 10−5 M). Compound 5a–c exhibited a very low fluorescence quantum yield ranging from 9–12% in DMSO–PBS buffer (1
:
1 ratio), which could be due to the self-aggregation of molecules. By using DMSO alone as a solvent increase in quantum yields (73%) was observed.
 |
| Fig. 2 (a) UV-vis spectra of 5a in different solvents; (b & c) UV titration of 5a in DMSO with PBS buffer and its corresponding plot of absorbance intensity vs. concentration; (d) emission spectra of 5a in dodecanol (1 × 10−5) and its response with respect to dilution [λex = 325 nm]; (e) plot of emission intensity vs. concentration of 5a in dodecanol; (f & g) fluorescence titration of 5a in DMSO with PBS buffer [λex = 325 nm] and its corresponding plot of wavelength vs. concentration. In titration experiments, direction of arrow show the response of absorption and emission intensity with piecemeal addition of 100 μL of corresponding solvent. 2 mL of initial volume of solution (1 × 10−5) was taken for titration experiments. | |
Similarly self-assembly of 5b and 5c was also identified by using UV and fluorescence studies (Fig. S4 and S5†). From these result, we resolve that at higher concentration, 5a and 5b form gel in decanol and dodecanol, and at lower concentration 5a–c in DMSO–water (1
:
1 mixture) forms self-assembled nanostructures (nano-sheet and nano-flakes). Fluorescence of self-assembled system was not quenched even in extreme pH conditions (pH 4 & 10), and thus this system can be applied for cell imaging under physiologically important conditions at various pH values (Fig. S6†). In order to take the advantage of the utility of self-assembly of 5a–c in DMSO–water mixture for live cell imaging application, normal (fibroblast) cells and PC3 human prostate cancer cells16 were incubated with medium containing 5a–c [5a: 0.6 × 10−3 M, 5b: 0.4 × 10−3 M and 5c: 0.4 × 10−3 M (250 μg per 1000 μL)] for 24 h and cellular localization was traced using Laser Confocal Scanning Microscopy (LCSM). Self-assembled coumarin-coupled pyrenes 5a–c were uniformly located in the cytoplasm and perinuclear region of the cells. The green self-fluorescence arising from 5a–c can be readily observed. Fluorescence intensity decreases with increase in hydrophobicity of π-conjugated systems (Fig. 3). Endocytosis of nanoparticles involves four different mechanisms: clathrin-mediated endocytosis, caveolae mediated endocytosis, macropinocytosis and phagocytosis. Inhibitors such as sucrose and chlorpromazine (blocking agents of clathrin-coated pit formation) and filipin (an inhibitor of caveolae-associated endocytosis) had no significant inhibition effect on the nanoparticle uptake. Nocodazole, an inhibitor of macropinocytosis decreases the uptake of nanoparticle up to 60%. The prominent cell uptake pathway for self-assembled nanoparticles are macropinocytosis and phagocytosis.16 In fibroblast no damage in cells were observed, which implies the low cytotoxicity of fibroblast and also identified from cytotoxicity assay. In addition, the death of majority of PC3 cells were observed, which is due to anticancer activity of 5a–c, as identified based on cell membrane rupture and the overflow of cytoplasm (Fig. S7†). Coumarin based anti-cancer drug, decursin inhibits Wnt/β-catenin pathway and cellular proliferation.17 We hypothesize that 5a–c might also follow similar of mechanism. This self-fluorescent probe would potentially facilitate a simultaneous combination of optical diagnosis and treatment for prostate cancer.
 |
| Fig. 3 LCSM images of (a–c) fibroblast incubated with 5a–c and (d–f) PC3 prostate cancer cells incubated with 5a–c for 24 h respectively. Green from self-fluorescent π-conjugated systems 5a–c and blue from Hoechst strain used to differentiate nucleus. | |
In order to verify the biocompatibility of the fluorescent nano-structures, it is necessary to evaluate its in vitro cytotoxicity.18 We have evaluated the cytotoxicity of compounds 5a–c by MTS assay on fibroblast and PC-3 cells. The maximum absorbance (λabs) of formazan, produced by the cleavage of MTS by dehydrogenases in living cells, at a wavelength of 490 nm is directly proportional to the number of live cells in the MTS assay. The λabs for compound 5a–c in DMSO–water or DMSO–PBS buffer (1
:
1 mixture) was observed between 340–360 nm, which would not interfere with MTS assay. Cytotoxicity assay shows that the fluorescent lipophilic compounds 5a–c showed no significant cytotoxic effect on fibroblast. After 24 h incubation, suppression in the proliferation of PC3 cells were observed and not in fibroblast. Inhibition in the proliferation of PC3 cells increases with increase in concentration of coumarin-coupled pyrene derivatives 5a–c (Fig. S8†).
In conclusion, π-conjugated systems derived from renewable resource that self-assemble into supramolecular structures through hydrogen bonding and π–π stacking of pyrene units are reported. The aggregation of compounds in different solvents strongly influences its optical properties resulting in a redshift and increase of emission intensity. Under higher concentration, it form a gel and in lower concentration, self-assembled nanostructures was observed. Nanomaterial obtained under lower concentration were used for fibroblast and PC3 prostate cancer cell imaging applications. We hypothesise that suppression in the proliferation of PC3 cells might be due to the inhibition of Wnt/β-catenin pathway.17 These self-assembled soft materials provide a promising platform for direct cell imaging and disease therapeutics. Further detailed investigation on mode of action is in progress in our research laboratory.
Acknowledgements
This work was financially supported by the Department of Science and Technology (IFA-CH-04 and #SB/FT/CS-024/2013), India and Board of Research in Nuclear Science (#37(1)/20/47/2014), Department of Atomic Energy, India. S.N thank DST, New Delhi for spectrofluorometer under the FIST sensor project scheme to SASTRA University. GJ acknowledges the support from the Gulf of Mexico Research Initiative (GoMRI) through the Consortium for the Molecular Engineering of Dispersant Systems (C-MEDS) subcontract (TUL-626-11/12). We also thank SASTRA University for TRR research fund. We thank CARISM, SASTRA University for NMR facility.
Notes and references
-
(a) D. Ma, K. Tu and L. M. Zhang, Biomacromolecules, 2010, 11, 2204 CrossRef CAS PubMed;
(b) Y. Qiu and K. Park, Adv. Drug Delivery Rev., 2001, 53, 321 CrossRef CAS;
(c) K. Y. Lee and D. J. Mooney, Chem. Rev., 2001, 101, 1869 CrossRef CAS PubMed;
(d) M. J. Wilson, S. J. Liliensiek, C. J. Murphy, W. L. Murphy and P. F. Nealey, Soft Matter, 2012, 8, 390 RSC;
(e) V. Jayawarna, M. Ali, T. A. Jowitt, A. F. Miller, A. Saiani, J. E. Gough and R. V. Ulijn, Adv. Mater., 2006, 18, 611 CrossRef CAS.
-
(a) B. D. MacCraith, C. M. McDonagh, G. OKeeffe, A. K. McEvoy, T. Butler and F. R. Sheridan, Sens. Actuators, B, 1995, 29, 51 CrossRef CAS;
(b) J. Wang, Anal. Chim. Acta, 1999, 399, 21 CrossRef CAS;
(c) S. Banerjee, R. K. Das and U. Maitra, J. Mater. Chem., 2009, 19, 6649 RSC;
(d) A. Chakrabarty and U. Maitra, J. Phys. Chem. B, 2013, 117, 8039 CrossRef CAS PubMed;
(e) P. K. Vemula and G. John, Chem. Commun., 2006, 2218 RSC.
-
(a) W. Jin and J. D. Brennan, Anal. Chim. Acta, 2002, 461, 1 CrossRef CAS;
(b) P. D. Thornton, R. J. Mart, S. J. Webb and R. V. Ulijn, Soft Matter, 2008, 4, 821 RSC;
(c) M. Ghosh, S. Maiti, S. Brahmachari and P. K. Das, RSC Adv., 2012, 2, 9042 RSC;
(d) T. Kar, S. K. Mandal and P. K. Das, Chem. Commun., 2012, 48, 8389 RSC;
(e) B. Escuder, F. Rodrguez-Llansola and J. F. Miravet, New J. Chem., 2010, 34, 1044 RSC;
(f) Q. Wang, Z. Yang, X. Zhang, X. Xiao, C. K. Chang and B. Xu, Angew. Chem., Int. Ed., 2007, 46, 4285 CrossRef CAS PubMed;
(g) N. M. Sangeetha and U. Maitra, Chem. Soc. Rev., 2005, 34, 821 RSC;
(h) S. Srinivasan, V. K. Praveen, R. Philip and A. Ajayaghosh, Angew. Chem., Int. Ed., 2008, 47, 5675 CrossRef;
(i) Y. Li, B. G. Cousins, R. V. Ulijn and I. A. Kinloch, Langmuir, 2009, 25, 11760 CrossRef CAS PubMed;
(j) A. M. Bieser and J. C. Tiller, Supramol. Chem., 2008, 20, 363 CrossRef CAS;
(k) L. A. Estroff and A. D. Hamilton, Angew. Chem., Int. Ed., 2000, 39, 3447 CrossRef CAS;
(l) S. Kiyonaka, K. Sada, I. Yoshimura, S. Shinkai, N. Kato and I. Hamachi, Nat. Mater., 2004, 3, 58 CrossRef CAS PubMed;
(m) J. H. Jung, G. John, M. Masuda, K. Yoshida, S. Shinkai and T. Shimizu, Langmuir, 2001, 17, 7229 CrossRef CAS;
(n) S. Vauthey, S. Santoso, H. Y. Gong, N. Watson and S. G. Zhang, Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 5355 CrossRef CAS PubMed;
(o) P. K. Vemula, N. Wiradharma, J. A. Ankrum, O. R. Miranda, G. John and J. M. Krap, Curr. Opin. Biotechnol., 2013, 24, 1 CrossRef PubMed;
(p) M. Kumar, N. Kumar, V. Bhalla, P. R. Sharma and T. Kaur, Org. Lett., 2012, 14, 406 CrossRef CAS PubMed;
(q) B. Roy, P. Bairi and A. K. Nandi, RSC Adv., 2014, 4, 1708 RSC.
- R. G. Weiss and P. Terech, Molecular Gels, Materials with Self-Assembled Fibrillar Networks, Springer, New York, 2006 Search PubMed.
-
(a) S. Nagarajan, T. M. Das, P. Arjun and N. Raaman, J. Mater. Chem., 2009, 19, 4587 RSC;
(b) S. Nagarajan, P. Ravinder, V. Subramanian and T. M. Das, New J. Chem., 2010, 34, 123 RSC;
(c) G. John, B. Vijay Sankar, S. R. Jadhav and P. K. Vemula, Langmuir, 2010, 26, 17843 CrossRef CAS PubMed;
(d) G. John, M. Masuda, Y. Okada, K. Yase and T. Shimizu, Adv. Mater., 2001, 13, 715 CrossRef CAS.
-
(a) T.-F. Yeh, C.-Y. Lin and S.-T. Chang, J. Agric. Food Chem., 2014, 62, 1706 CrossRef CAS PubMed;
(b) S. Robert, C. Bertolla, B. Masereel, J.-M. Dogne and L. Pochwet, J. Med. Chem., 2008, 51, 3077 CrossRef CAS PubMed;
(c) A. Maresca, C. Temperini, L. Pochet, B. Masereel, A. Scozzafava and C. T. Supuran, J. Med. Chem., 2010, 53, 335–344 CrossRef CAS PubMed.
- S. S. Babu, V. K. Praveen and A. Ajayaghosh, Chem. Rev., 2014, 114, 1973 CrossRef CAS PubMed and reference cited therein.
-
(a) L. K. Aggarwal, P. C. Thapliyal and S. R. Karade, Prog. Org. Coat., 2007, 59, 76 CrossRef CAS;
(b) T. Abhijit, J. Trissa and V. Vasant, U. S. Pat. Appl. Publ., US20120024527 A1 20120202, 2012;
(c) A. L. M. Reddy, S. Nagarajan, P. Chumyim, S. R. Gowda, P. Pradhan, S. R. Jadhav, M. Dubey, G. John and P. M. Ajayan, Sci. Rep., 2012, 2, 960 Search PubMed.
-
(a) V. S. Balachandran, S. R. Jadhav, P. K. Vemula and G. John, Chem. Soc. Rev., 2013, 42, 427 RSC;
(b) H. S. P. Rao, M. Kamalraj, J. Swain and A. K. Mishra, RSC Adv., 2014, 4, 12175 RSC;
(c) B. Lochab, S. Shukla and I. K. Varma, RSC Adv., 2014, 4, 21712 RSC;
(d) C. Voirin, S. Caillol, N. V. Sadavarte, B. V. Tawade, B. Boutevin and P. P. Wadgaonkar, Polym. Chem., 2014, 5, 3142 RSC;
(e) W. Kiratitanavit, S. Ravichandran, Z. Xia, J. Kumar and R. Nagarajan, J. Renewable Mater., 2013, 1, 289 CrossRef CAS.
-
(a) S. Kobayashi, H. Uyama and R. Ikeda, Chem.–Eur. J., 2001, 7, 4754 CrossRef CAS PubMed;
(b) L. Faure, S. Nagarajan, H. Hwang, C. L. Montgomery, B. R. Khan, G. John, P. Koulen, E. B. Blancaflor and K. D. Chapman, J. Biol. Chem., 2014, 289, 9340 CrossRef CAS PubMed.
- J. Yao, W. Dou, W. Qin and W. Liu, Inorg. Chem. Commun., 2009, 12, 116 CrossRef CAS.
-
(a) D. Mandal, T. Kar and P. K. Das, Chem.–Eur. J., 2014, 20, 1349 CrossRef CAS PubMed;
(b) P. Xue, R. Lu, L. Zhao, D. Xu, X. Zhang, K. Li, Z. Song, X. Yang, M. Takafuji and H. Ihara, Langmuir, 2010, 26, 6669 CrossRef CAS PubMed;
(c) S. S. Babu, K. K. Kartha and A. Ajayaghosh, J. Phys. Chem. Lett., 2010, 1, 3413 CrossRef CAS;
(d) F. García, J. Buendía, S. Ghosh, A. Ajayaghosh and L. Sánchez, Chem. Commun., 2013, 49, 9278 RSC;
(e) K. Sakakibara, P. Chithra, B. Das, T. Mori, M. Akada, J. Labuta, T. Tsuruoka, S. Maji, S. Furumi, L. K. Shrestha, J. P. Hill, S. Acharya, K. Ariga and A. Ajayaghosh, J. Am. Chem. Soc., 2014, 136, 8548 CrossRef CAS PubMed.
- G. John, G. Zhu, J. Li and J. S. Dordick, Angew. Chem., Int. Ed., 2006, 45, 4772 CrossRef CAS PubMed.
- P. A. Korevaar, C. Schaefer, T. F. A. de Greef and E. W. Meijer, J. Am. Chem. Soc., 2012, 134, 13482 CrossRef CAS PubMed.
-
(a) U. Rosch, S. Yao, R. Wortmann and F. Wurthner, Angew. Chem., Int. Ed., 2006, 45, 7026 CrossRef PubMed;
(b) A. Ajayaghosh, C. Vijayakumar, R. Varghese and S. George, Angew. Chem., Int. Ed., 2006, 45, 456 CrossRef CAS PubMed.
-
(a) S. C. Lee, N. Y. Kang, S. J. Park, S. W. Yun, Y. Chandran and Y. T. Chang, Chem. Commun., 2012, 48, 6681 RSC;
(b) M. Vendrell, D. Zhai, J. C. Er and Y. T. Chang, Chem. Rev., 2012, 112, 4491 CrossRef PubMed;
(c) S. W. Yun, N. Y. Kang, S. J. Park, H. H. Ha, Y. K. Kim, J. S. Lee and Y. T. Chang, Acc. Chem. Res., 2014, 47, 1277 CrossRef CAS PubMed;
(d) D. Zhai, W. Xu, L. Zhang and Y. T. Chang, Chem. Soc. Rev., 2014, 43, 2402 RSC;
(e) H. Gao, Z. yang, S. Zhang, S. Cao, S. Shen, Z. Pang and S. Jiang, Sci. Rep., 2013, 3, 2534 CrossRef CAS PubMed;
(f) E. J. New, A. Congreve and D. parker, Chem. Sci., 2010, 1, 111 RSC.
- G.-Y. Song, J.-H. Lee, M. Cho, B.-S. Park, D.-E. Kim and S. Oh, Mol. Pharmacol., 2007, 72, 1599 CrossRef CAS PubMed.
- Y. Chen, P. A. Wilbon, J. Zhou, M. Nagarkatti, C. Wang, F. Chub and C. Tang, Chem. Commun., 2013, 49, 297 RSC.
Footnote |
† Electronic supplementary information (ESI) available: Experimental details, figures, tables and copy of NMR spectras. See DOI: 10.1039/c4ra07710e |
|
This journal is © The Royal Society of Chemistry 2014 |
Click here to see how this site uses Cookies. View our privacy policy here.